Menu Back toS26-eSource-in-Clinical-Trials-Global-Japan-Use-Cases

16th DIA Japan Annual Meeting 2019

Delivering Rational Medicine for All People in the Globe

[S26] eSource in Clinical Trials -Global/Japan Use Cases-

Session Chair(s)

Toshihiko  Doi, MD, PhD

Toshihiko Doi, MD, PhD

  • Deputy Director / Chief, Experimental Therapeutics
  • National Cancer Center Hospital East, Japan
The value of eSource is indisputable. TransCelerate member companies and other select organizations will share experiences of eSource implementation and discuss lesson learned to continue to progress towards the digitalization of clinical trials. Discuss the application of eSource in clinical trials from an industry member consortium and others; Identify important lessons learned for future application and adoption of eSource within their organizations and continue to uncover unknowns in this emerging space related to technology and standards in need of further advancement.


Matthew  Moyer, MBA, MS, PMP

Digitally Enabled Patient-Centric Clinical Trials – Current State and Future Opportunities

Matthew Moyer, MBA, MS, PMP

  • Director
  • Merck & Co., Inc., United States
Jesper  Kjaer, MS

TransCelerate eSource Regulatory Landscape Assessment

Jesper Kjaer, MS

  • Director, DM Process & Innovation
  • Novo Nordisk A/S, Denmark
Amy  Cramer, BSN, MS, RN

Comparison of eSource Approaches

Amy Cramer, BSN, MS, RN

  • Global Product Development Strategic Partnerships
  • Pfizer Inc, United States
Yuichi  Yamada

The Experience of DDC (Direct Data Capture) Introduction and Our Future Scope

Yuichi Yamada

  • Data Manager, Biostatistics Department
  • Shionogi & Co., Ltd., Japan